Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. EP Biocomposites's Revenue for the
six
months ended in Mar. 2026 was ₹95.7 Mil. EP Biocomposites's average Accounts Receivable for the
six
months ended in Mar. 2026 was ₹108.0 Mil.
Hence, EP Biocomposites's Receivables Turnover for the
six
months ended in Mar. 2026 was 0.89.
EP Biocomposites (BOM:543595) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
EP Biocomposites Receivables Turnover Related Terms
EP Biocomposites Receivables Turnover Historical Data
* Premium members only.
The historical data trend for EP Biocomposites's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543595 vs TT, JCI, CARR: Receivables Turnover Comparison
For the Building Products & Equipment subindustry, EP Biocomposites's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EP Biocomposites Receivables Turnover vs Construction Industry
For the Construction industry and Industrials sector, EP Biocomposites's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where EP Biocomposites's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EP Biocomposites (BOM:543595) has a Receivables Turnover of 0.89 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on EP Biocomposites and its competitors. According to the industry distribution chart, EP Biocomposites ranks #1513 out of 1767 companies in the Construction industry, placing it in the top 85.6%.
Is EP Biocomposites' Receivables Turnover too high?
EP Biocomposites' current Receivables Turnover is 0.89. The Construction industry median Receivables Turnover is 4.81. EP Biocomposites' value of 0.89 is 81.5% below this industry median. Based on the distribution chart, EP Biocomposites ranks #1513 out of 1767 companies in the Construction industry, which is in the bottom quartile relative to peers. Overall, EP Biocomposites has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EP Biocomposites' Receivables Turnover compare to TT and JCI?
According to the Construction industry distribution chart, EP Biocomposites ranks #1513 out of 1767 companies for Receivables Turnover. This places EP Biocomposites in the lower half of its industry. The industry median Receivables Turnover is 4.81. EP Biocomposites' value of 0.89 is 81.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Construction company?
The median Receivables Turnover among Construction companies is 4.81, based on 1,767 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EP Biocomposites's current Receivables Turnover of 0.89 is 81.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on EP Biocomposites and its competitors. For the Construction industry, the median Receivables Turnover is 4.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EP Biocomposites's current Receivables Turnover is 0.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EP Biocomposites stock overvalued right now?
Based on GuruFocus' analysis, EP Biocomposites (BOM:543595) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹205.07, compared to a current price of ₹94.99 — trading 53.7% below its estimated fair value. The current Receivables Turnover is 0.89 and 81.5% below the Construction industry median of 4.81. EP Biocomposites' overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For EP Biocomposites (BOM:543595), the current Receivables Turnover is 0.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EP Biocomposites (BOM:543595) Overvalued in 2026?
Based on GuruFocus' analysis, EP Biocomposites stock appears to be undervalued.
The current stock price of ₹94.99 is trading 53.7% below its estimated GF Value™ of ₹205.07.
GuruFocus considers EP Biocomposites to be Significantly Undervalued.
Key valuation signals for BOM:543595:
Receivables Turnover: 0.89
GF Value™: ₹205.07 vs. price of ₹94.99 (53.7% below fair value)
Industry Position: 81.5% below the Construction median (#1513 of 1767)
No single metric tells the full story. See the BOM:543595 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EP Biocomposites Ltd is the manufacturer and supplier of fibre reinforced polymers products such as door shutters, frames, Biodigestor Tanks, Bio toilets and allied products for construction and Industrial applications. The company focus on giving sanitation solutions to those who do not have access to toilets, as well as to those who have toilets but face trouble treating and managing the waste through septic tanks. The company also provides sanitation infrastructure and human waste management solutions and services, involving simple bio-digester technology licensed from the Defence Research and Development Organisation (DRDO) and Industry Interface and Technology Management, operating under the aegis of DRDO, Ministry of Defence, Government of India.
72GF Score
Get the complete analysis for BOM:543595
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543595 has been successfully added to your 
